| Tag | Content |
|---|
EnhancerAtlas ID | HS193-02417 |
Organism | Homo sapiens |
Tissue/cell | U87 |
Coordinate | chr1:161581560-161583170 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| EWSR1-FLI1 | MA0149.1 | chr1:161582764-161582782 | CCTCCCTTCCTTCCTTTG | - | 6.66 | | EWSR1-FLI1 | MA0149.1 | chr1:161582760-161582778 | CTTTCCTCCCTTCCTTCC | - | 9.01 | | KLF5 | MA0599.1 | chr1:161582351-161582361 | GGGGCGGGGC | - | 6.02 | | ZNF263 | MA0528.1 | chr1:161582760-161582781 | CTTTCCTCCCTTCCTTCCTTT | - | 6.12 | | ZNF263 | MA0528.1 | chr1:161582205-161582226 | TGAGGAGTGCGGGGGGGAAGA | + | 6.2 |
|
| | Number of super-enhancer constituents: 14 | ID | Coordinate | Tissue/cell |
| SE_07357 | chr1:161580788-161584698 | Brain_Hippocampus_Middle_150 | | SE_09867 | chr1:161579384-161583530 | CD14 | | SE_12235 | chr1:161581303-161583400 | CD3 | | SE_12654 | chr1:161581792-161582273 | CD34_adult | | SE_12771 | chr1:161581912-161582301 | CD34_fetal | | SE_12771 | chr1:161582578-161582932 | CD34_fetal | | SE_13494 | chr1:161579645-161584358 | CD34_Primary_RO01536 | | SE_15335 | chr1:161579226-161584686 | CD4_Memory_Primary_7pool | | SE_16693 | chr1:161581295-161583416 | CD4_Naive_Primary_8pool | | SE_20036 | chr1:161580924-161584169 | CD56 | | SE_20740 | chr1:161577990-161584457 | CD8_Memory_7pool | | SE_22436 | chr1:161580812-161584433 | CD8_primiary | | SE_39938 | chr1:161580902-161584380 | K562 | | SE_53727 | chr1:161580858-161583334 | Spleen |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 2 | Chromosome | Start | End |
| chr1 | 161582451 | 161582780 | | chr1 | 161582212 | 161582506 |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH01I161611 | chr1 | 161580791 | 161583390 |
|
Enhancer Sequence | ACAGGAAAAA TAGATTTAGT TCTATATGTG CAGAGAAGCA CAAATAATTT TCGTAAATGT 60
AGATACCCAG GATAAAACGC AGTGTTGACC GATCGAAAAG TCTTTCTCTA AGAATTCAAA 120
CATAATTGCT GGTTGGTTCA AATCAGGAGG AAAAGTAAGG ATGGAAAACA TACGTTGTCA 180
AAAGTGGGAT TCGAACCCAC GCCTCCAGCG GAGGGTGCGA TTTGAACGCA GCGCCTTAAG 240
ACTGCTCGGC CATCCTGACA CACGTTTTGC TAAACTTCCT AATTTCTCCT AATTTTATCA 300
TATACTGATG GTGCACGCTA TCAGGTCACA TTAATGTGTC TATTTACTGT TTCAAATAAA 360
ATTGTAACTC TCTCTAGACC TTGTCGCAAA GCGGGAAAAA TGAAACAGCC TCCGACAGCT 420
CTTTCCTCTT TCCTCACTAC CCAAACTAAA CCTTAAGGCT CCATTTTCCC TGGCGACTCT 480
TCGAGCGCCC CTCTGCTTCT GTAGAGGGGT CGAGCCATGT CAAGGTAGAC CCTGTGTCGG 540
CCCGTCTCCC TCGGATCCTC CGCACCAATC ACTGTTGCTG AATCCGACAC CCGGCGGATC 600
CAGTGCGGAG TCTCGAACAG CTGCGGAGCT GGGAGCTACG GGACATGAGG AGTGCGGGGG 660
GGAAGAGAAG ACGGCGGAGG AAAATCCCCC GGCGGTGCTC AACTGCGGCT TTCTCTCTCG 720
GCTGTGAGCC GGCTCCGCCC TCCGGCTTCC AGAGCAAGTG GCTTCTGCGT TCACCGCCCC 780
CCGCCGTTTG TGGGGCGGGG CCGATTCATA AGAATCGGTT CTCACCAATG GAGGGCTTAG 840
CATGTTTAAC CTCAGGATCA TAAACAAAAG ACACTGCTAG AACGGTCGGG AAAGTCATAC 900
GCTTTGCTTA TCTTATATAT AGATTTCTAA AATTCCAAAC CGGGGACGCG TTGGTGGTGT 960
AGTGGTGAGC ACAGCTGCCT TTCAAGCAGT TAACGCGGGT TCGATTCCCG GGTAACGAAA 1020
CGTTTTTGTC TTTCCTTCTA CGAAAAACTT TTCTGAGCCG GAGCCTCCAG CGCGCTGTGT 1080
ATTCGTTTTA CGCCTCAACG AAACTGCAGC AATACCTCAC TTTCCGTACT CGCTTCCTGT 1140
CTTTCCCCTG GCCTCTTTCT AAACCCAGGC TTTTTTTGAA GGGATTAAAT TCTGATGGTT 1200
CTTTCCTCCC TTCCTTCCTT TGTAAACTTC CAACTCTTGA GGAATCTTTG GGATCATTTC 1260
AATCCTGGGA TGAGTCTTAG CTTCAGAAAG GGGCTCTTGT GTCTTCACTT GCGAGGTTCA 1320
TTCGCTAGCC TCTACAAATC ATCACTTAAG CCCCTAATTA TTCCCGGCCG AGGTCCTAGG 1380
CTAAGGTCCC GGGCCAAGCT TTCTAATTAG TCCCAGGCCA AGGTCCCAGG CCAACCTAAA 1440
TCACGCATTC TCCAAAACAG CCGGCAAACT AAGCACATTC CTTCCCGTTT CCAGTCCATA 1500
AACCCCCCCC CCCAAGTGGC CTCATAGTAA GCAACTCATT CGGGCCCCCT CTCTGCTGGC 1560
AAAAAGCTCA GATGTACTGG ACTGTGCATT TGATTTGGAA CTGAGTTACA 1610
|
